General Information of This Metabolic Reaction (MR) (ID: MR001737)
Formula
CYP3A4 ...
SVG example
Reactant Nifedipine Product 2,6-dimethyl-4-(2-nitrophenyl)-5-methoxycarbonyl-pyridine-3-carboxylic acid
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 3A4 (CYP3A4) DME Info
Cytochrome P450 3A5 (CYP3A5) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001738 Nifedipine Dehydronifedipine Oxidation - Dehydrogenation Nifedipine [1], [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001761 Nisoldipine Nisoldipine metabolite M1 Unclear Nisoldipine [3]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001736 2,6-dimethyl-4-(2-nitrophenyl)-5-methoxycarbonyl-pyridine-3-carboxylic acid 2-hydroxymethyl-pyridine carboxylic acid Unclear Nifedipine [4]
MR001758 Nisoldipine metabolite M1 Nisoldipine metabolite M2 Oxidation - Dehydrogenation Nisoldipine [3]
References
1 The first pass metabolism of nifedipine in man Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x.
2 Pharmacokinetics and metabolism of nifedipine Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18.
3 Clinical pharmacokinetics of nisoldipine coat-core Clin Pharmacokinet. 1998 Sep;35(3):191-208. doi: 10.2165/00003088-199835030-00003.
4 CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers Pharmacogenomics J. 2004;4(1):34-9. doi: 10.1038/sj.tpj.6500218.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.